(72.7%) were within the recommended screening age (30 years and older). Annual screening coverage rates ranged from 2.9-4.2% of the population of women aged 30 years and older. The cumulative screening coverage during the four years was 13.7%. The mean smear adequacy rate during this time was 98.5%. Of the 202 251 smears, 5 237 (2.5%) reflected high-grade squamous intraepithelial lesions, while 238 (0.2%) contained malignant lesions.
Introduction
Cervical cancer is a public health problem globally, especially in developing countries, where 80% of cases occur. 1 While most developed countries have experienced a significant decrease in the incidence of cervical cancer over the years, the disease has become the most common cancer and the leading cancer-related cause of death among women in subSaharan Africa countries. 2 The majority of women who develop the disease in these countries seek treatment at advanced stages, when treatment is no longer effective. 1, 2 It is estimated that at least 3 000 women die of cervical cancer in South Africa annually. 1, 2 Cervical cancer is detectable in the early stages through screening for precancerous cervical lesions using the safe and cost-effective cytology-based Papanicolaou test (commonly referred to as the Pap smear). 3 If detected in the early stages, cervical cancer is preventable or curable by surgical removal of the precancerous lesions. Population-wide cervical cancer screening programmes have been effective in reducing the incidence of the disease in developed and industrialised countries. 4 However, in most subSaharan African countries, cervical cancer prevention and screening programmes are either nonexistent or rudimentary. 4 Where screening programmes exist, coverage is often suboptimal because of a poorly developed health infrastructure and inadequate health resources, as well as the existence of competing health priority programmes for human immunodeficiency virus/acquired immune deficiency syndrome and tuberculosis. 4 Because of such challenges, the majority of women in these countries do not have access to cervical cancer screening services.
South Africa launched a population-wide national cervical cancer control programme in 2001. 5 The goal of the programme was to screen at least 70% of women in the target age group (30 years of age and older) within the first 10 years of implementing the programme, and to provide at least three free Pap smears in a woman's lifetime at 10-year intervals. 5 In line with this national policy, the Limpopo Provincial Department of Health commenced a provincial cervical cancer screening programme in 2001. 6 The current article describes the performance of the cervical cancer screening programme in the Limpopo province between 2007 and 2010, with an emphasis on distribution, screening coverage, adequacy of smears and reported cytological abnormalities, using data routinely collected by the National Health Laboratory Services (NHLS).
Method

Study setting and design
The Limpopo province is located in the northern part of South Africa and is divided into five administrative districts: Waterberg, Sekhukhune, Vhembe, Mopani and Capricorn. The province has a total population of approximately 5.8 million people. Women contribute an estimated 53%. The Limpopo province implemented the cervical cancer screening programme in 2001, in line with the national cervical screening policy. The current study uses a retrospective descriptive analytic approach for data that were collected from the cervical cancer screening programme in the Limpopo province through the NHLS.
Cervical cancer screening in the Limpopo province
In line with the national cervical screening policy, [5] [6] [7] the Limpopo province offers cervical screening for free to women aged 30 years and older who access primary healthcare services in the province. After collection of the cervical smear, the women are asked to return after a period of three weeks for the cytology results. When an abnormal smear is detected, the woman is referred to an appropriate health facility for colposcopy services and further treatment.
A facility-based data-collection tool (the Pap smear register) captures the identifying and demographic information, the Pap smear results and relevant followup information for each screened woman. Aggregated monthly summaries are submitted to the next health unit level through the local health information system. Collected smears are sent to the local NHLS laboratory for analysis. Smears are evaluated in the laboratory by trained cytotechnicians and pathologists using the 2001 Bethesda System to report cervical cytology results. 8 All clinical specimens that are analysed within the NHLS laboratory network in South Africa are captured electronically through a real-time laboratory information system onto a centralised data repository, called the Central Data Warehouse (CDW). The data on the CDW include all the demographical information and results that are captured on the laboratory information system. 
Data management and analysis
The study population comprised women with Pap smears that were submitted to the NHLS for evaluation between January 2007 and December 2010. Data were analysed using the Stata® statistical software (Release 11, StataCorp, 2009, College Station, Texas). Categorical variables were summarised using proportions (percentages). The chi-square test for trend was used for statistical significance of observed trends. A p-value of less than 0.05 (p-value < 0.05) was considered to be statistically significant. The data variables were also used to describe or evaluate various components of the cervical cancer screening programme in the Limpopo province.
The following programme indicators were evaluated:
• Appropriate age for screening was calculated as the proportion of examined smears that were collected from women over the age of 30 years.
• Smear adequacy was calculated as the proportion of submitted smears that were classified as adequate for cytological examination in the laboratory.
• The proportion of abnormal smears was calculated as the percentage of examined smears that were detected containing cytological abnormalities according to the Bethesda System. • Smear coverage was calculated as the proportion of the targeted population for which smears were submitted for cytology. The target population was the total number of women aged 30 years and older, residing in the Limpopo province for each year. South Afr J Gynaecol Oncol
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Results
During the period under study, a total of 202 251 cervical smears were submitted to the NHLS for cytological examination through the provincial cervical screening programme in the Limpopo province. The number of submitted cervical smears increased by 60% from 39 029 in 2007 to 63 517 in 2010 (Table I ). An overall increasing trend was observed across all five health districts in the Limpopo province for the observed years, except in 2009 when there was a notable decrease in all five health districts in the number of cervical smears that were submitted for examination. Figure 1 shows the age distribution of the women enrolled into the screening programme during the four-year period. Of the 202 251 smears, the age of the screened women had not been recorded for 22 235 (10.9%). Of the 180 016 smears where the age was captured, 116 184 (64.5%) of the women were aged between 25 and 49 years. However, the data also show that nearly a third (49 105, 27.3%) of the smears were collected from women who were below the minimum recommended age at which cervical cancer screening in South Africa is started (30 years). The proportion of collected smears from the women within the appropriate age for screening ranged from 70.9-78.6% during the four-year period (Table II) .
The annual cervical screening coverage ranged from 2.9-4.2 per 100 women between 2007 and 2010 (Table  III) . During the four-year period, the province achieved Table IV shows the mean smear adequacy rates for each year. During the four-year study period, the Limpopo province achieved a mean smear adequacy rate of 98.5%, well above the national minimum performance target of 70%. All five districts maintained very high smear adequacy rates.
Of the 202 251 cervical smears submitted to the NHLS for an examination during the four years, 1 806 (0.9%) were unsuitable for examination, and another 952 (0.5%) had an inconclusive morphological appearance. 
Discussion
The findings show a steady increase in the number of cervical smears that were submitted for cytology between 2007 and 2010 in the Limpopo province. At the launch of the national cervical cancer control programme in 2001, the goal was to incrementally increase coverage, and ultimately to screen at least 70% of women in the target age group within 10 years of initiation of the programme. 5, 9 In order to achieve this goal, health departments and partner organisations made some effort at community level, for example, through regular media campaigns, to educate, inform and invite women for screening. In addition, the number of health professionals who were trained in the collection and evaluation of smears also increased. 5, 9, 10 Possibly, these efforts contributed to the increase in the number of women who presented for cervical screening.
Almost a third of the smears were collected from women below the age of 30 years. In South Africa, the national cervical cancer screening policy recommends screening from the age of 30 years. Some previous studies that were carried out in South Africa also reported that screening was generally performed in younger women. 11 Currently, most parts of the country do not offer population-wide cervical screening. Health facilities conduct opportunistic screening that mainly targets women seeking postnatal care and family planning services. Women seeking such services are generally younger, which partly explains why a higher proportion of the smears were carried out in these younger women.
Over the past decade, epidemiological evidence has shown that HIV-positive women have a higher prevalence of human papilloma virus infection (a precursor of cervical cancer) and are at higher risk of fast progression to cervical cancer. 12 Although the national guidelines did not specify the appropriate age for cervical screening in HIV-positive women until recently, in 2010, it is possible that some of the screening that was carried out on younger women was performed as routine screening on HIV-positive women. In addition, poor knowledge and awareness of the appropriate age for screening among staff conducting the cervical screening possibly contributed to screening of women below the recommended age. 5, 9, 10, 13 Performing smears on women who fall outside the population targeted by the screening programme diverts much-needed resources from the population at highest risk of the disease, and thus undermines the screening programme.
Our findings show that LSIL were more prevalent in younger women and the prevalence decreased with advancing age. According to the Bethesda System for reporting cervical cytological diagnoses, the LSIL category includes changes that are consistent with the human papillomavirus (HPV) infection, mild dysplasias and Grade 1 cervical intraepithelial neoplasias.
14 Epidemiological data show that the incidence of HPV infection increases after the onset of sexual activity, peaks around the age of 30 years, and then declines with increasing age. 15, 16 This is because the majority of HPV infections regress to normal within a few months following the infection, 16, 17 thus explaining the inverse relationship between the prevalence of LSIL and increasing age. Similar patterns have been reported in studies that have been conducted in other parts of the country. [17] [18] [19] The data also show that the prevalence of HSIL and malignant lesions increased with advancing age from the age of 30 years approximately. These findings seem to support the current national cervical screening policy, which recommends the screening of women who are 30 years and older. Screening women above the age of 30 years has been found to be more effective in preventing stage 1B or even more advanced cervical cancer in older, rather than younger women. 19 However, our findings also show that 0.7% of the smears that were carried out in women younger than the age of 20 years reflected HSIL. This seems to pose a challenging question about when it is ideal to commence cervical screening. Some recent literature has suggested that the incidence of cervical dysplasia among adolescents has been on the increase. 20 Mostly, this has been attributed to early onset and increased sexual activity among young women, leading to increased exposure to HPV infection and resultant cervical abnormalities. 19, 20 Nonetheless, a number of studies have also shown that the majority of these preinvasive cervical lesions in adolescents will regress to normal without any intervention. 20 Screening programmes in developed countries have recommended the commencement of cervical screening from as early as 20 years old. 14, 20 Attaining high coverage rates in the target population is crucial for the success of any screening programme. The screening programme in Limpopo achieved a cumulative screening coverage of approximately 13.7% during the four years of study. South Africa, like most other developing countries, is characterised by a low coverage of cytology-based cancer screening programmes. 18, 21 When the screening programme was launched in 2001, the target was to screen at least 70% of women aged 30 years old and older by 2010. Although screening coverage rates for the period 2001-2006 could not be obtained, our findings suggest that the province may have failed to meet these targets. To achieve the 70% coverage target, the province needed to achieve annual coverage rates in excess of 7% for the 10 years. Other provinces in the country have also failed to meet this target. [21] [22] [23] Although there were notable increases in screening coverage rates across all the provinces between 2007 and 2010, none of the provinces achieved the target of 70%. 24 Several issues have been cited to explain the low coverage rates, including lack of awareness among the target population; inadequate trained personnel to perform the screening tests, read smears and interpret the results; poor communication between the screening sites and laboratories; and inaccessibility of the facilities to diagnose and treat patients who have been detected through the screening process. 25, 26 In addition, population-based surveys, conducted in settings similar to those in South Africa, have reported gross inequalities in screening coverage. 27 The women who are at highest risk of developing cervical cancer are among the least likely to be screened. 28 However, it is encouraging to note the gradual increase in screening coverage that occurred annually between 2007 and 2010.
Evaluation of smear specimen adequacy is considered to be an important quality assurance procedure in the laboratory in increasing the possibility of intraepithelial lesion detection and minimising the risk of false negative reporting. 29 This is especially important in resourcelimited settings, such as South Africa, where a woman may undergo screening only once in her lifetime. 29, 30 Conventionally, a cervical smear is considered to be satisfactory for evaluation if it has an estimated minimum of 8 000-12 000 clearly displayed squamous epithelial cells. 29, 30 The Limpopo province recorded high smear adequacy rates throughout the study period.
Recent scientific evidence has shown that a visual inspection of the cervix with acetic acid, and oncogenic HPV testing, are effective alternatives to the traditional cytology-based Pap smear test. 31, 32 Scientists have suggested that these new screening methods may well be more cost-effective and useful in countries with limited resources where the majority of the existing screening programmes have not shown clinically significant reductions in the incidence of cervical cancer. 26, 31, 33 Recently, the American Cancer Society released new guidelines for the early detection of cervical precancerous lesions and cancer, recommending concurrent screening using both the Pap smear and the HPV test. 34 However, in South Africa, even if the government does incorporate new screening methods into the national cervical screening policy, the existing low screening coverage rates will remain a considerable hindrance to the success of the screening programme.
Our study has some limitations that should be taken into consideration when interpreting the findings. Firstly, it relied on secondary data that had limited data elements. The success of a screening programme hinges upon the availability and accessibility of follow-up treatments for patients who are detected through screening. Our analysis could not evaluate the performance of the screening programme in terms of the follow-up treatments of patients who were detected through the provincial screening programme. Secondly, patients screened in the provincial screening programme were not allocated the same laboratory identification number during follow-up visits. Therefore, it is possible that some women could have presented for screening more than once during the four-year study period, and were captured more than once in the CDW database. Thirdly, 10.9% of the entries in the database had a missing date of birth, mainly owing to incompleteness of information during data collection and capturing of data in the main data warehouse. This could have resulted in underestimation of the appropriate age of screening and coverage. Fourthly, the analysed data in this study excluded women for whom cervical smears had been collected in private healthcare facilities and sent to private laboratories for analysis. This could also have resulted in underestimation of true screening coverage in the province. Despite these limitations, we believe that these findings provide a good account of the performance of the cervical cancer screening programme in the Limpopo province during the period.
Conclusion
The cervical cancer screening programme in Limpopo showed some improvement during the four-year study period, but still fell short of the national goals. The key areas that require strengthening include increasing the screening coverage among women at higher risk (30 years and older), and reducing the screening of younger women who are at a lower risk of cervical cancer. Future studies should explore the factors that contribute to the low coverage rates, and also examine the availability and uptake of follow-up treatments for women with abnormal diagnoses that are detected through the screening programme.
